摘要
目的:评价子宫内膜异位症3种治疗方案的经济学效果。方法:60例子宫内膜异位症患者随机分成A,B,C组,分别给予A组(曼月乐)、B组(孕三烯酮)、C组(诺雷德),观察3种治疗方案的疗效及安全性,运用药物经济学的成本-效果分析方法进行评价。结果:3种方案有效率分别为90%、95%、95%,成本分别为1540.743元、736.206元、5982.6元。结论:在同等疗效基础上孕三烯酮更有经济性优势。
Objective:To analyze economic effect of 3different therapeutic regimens for endometriosis.Methods:A total of 60 cases of Endometriosis patients Were randomly divided into 3groups,group A(LNG-IUS),group B(Gestrinone),group C(Goserelin),The curative efficacy and safety of 3therapies were recorded and evaluated using cost-effectiveness analysis in pharmacoeconomics.Results:The total effective rates of the 3groups(A,B and C)were 90%、95%and 95%respectively.The cost-effectiveness ratios were 1540.743yuan、736.206 yuan and 5982.6yuan,respectively.Conclusion:Gestrinone treatment is more reasonable.
出处
《中国医院用药评价与分析》
2016年第S1期26-27,共2页
Evaluation and Analysis of Drug-use in Hospitals of China
